As part of 4 All of us efforts to educate health professionals on AMR we are hosting a series of Webinars examining solutions to overcome this global challenge. You can catch up on our previous webinars here:


The Role of Diagnostics - Supported by Roche

12pm, June 16th


  • Dr Vicki Chalker PHD, Head, Respiratory and Vaccine Preventable Bacteria Reference Unit, National Infection Service, Public Health England
  • Liz Cross, Advanced Nurse Practitioner, Attenborough Surgery

This Webinar addressed the current role of Diagnostics both in-house and external for use by microbiologists, pharmacists, doctors, GP's and health professionals. Exploring the current testing speeds used by Laboratory Technicians, how diagnostics can be implemented, why should diagnostics be used, the cost of diagnostic investment compared to patient costs and the role of POC diagnostics in community care.

The Webinar sought to understand the true value diagnostics can bring to antibiotic stewardship and compare its value to that of educational techniques currently used by health professionals. 

Fighting the Growing Threat of Antimicrobial Resistance - Supported by Alere


  • Dr Till Bachmann
  • Dr Ann Van den Bruel
  • Dr Jayne Ellis

Lord Jim O’Neill, the UK Commercial Secretary to the Treasury and Chair of the Review on Antimicrobial Resistance, recently released a report laying out recommendations to fight the global threat of antimicrobial resistance (AMR).

Overuse of antibiotics, especially of broad spectrum antibiotics rather than targeted narrow spectrum therapies, has led to an increase in drug-resistant bacterial infections. This emerging health issue is poised to have devastating global consequences, making it impossible to treat previously curable diseases. AMR already contributes to 700,000 deaths a year, and the report warns that it could cause 10 million deaths a year and $100 trillion in lost global productivity by 2050 if nothing is done to stop its spread.

In recent years, advances in diagnostic technology have made rapid point-of-care testing possible for many diseases – enabling providers to immediately prescribe the most appropriate therapy during the course of a patient’s visit.